Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease-Reference-Cited by-同舟云学术

Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease

Published:2020-04-03 Issue:2 Volume:10 Page:641-651
ISSN:1877-7171
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:JPD

Author:

Alves Mariana¹²³,Caldeira Daniel²³⁴,Rato Miguel Leal²³⁵,Duarte Gonçalo S.²³,Ferreira Afonso N.²³⁴,Ferro José³⁵,Ferreira Joaquim J.²³⁶

Affiliation:

1. Serviço de Medicina III, Hospital Pulido Valente, CHULN, Lisbon, Portugal

2. Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

3. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

4. Serviço de Cardiologia, Hospital Universitário de Santa Maria, CAML, Centro Cardiovascular da Universidade de Lisboa – CCUL, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

5. Serviço de Neurologia, Departamento de Neurociências e Saúde Mental, CHULN, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

6. CNS – Campus Neurológico Sénior, Torres Vedras, Portugal

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference32 articles.

1. Epidemiology of Parkinson’s disease;Tysnes;J Neural Transm,2017

2. Heart Disease and Stroke Statistics-2019 Update: A report from the American Heart Association;Benjamin;Circulation,2019

3. Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment;Günaydin;J Geriatr Cardiol,2016

4. Cardiovascular and mortality risks in Parkinson’s disease patients treated with entacapone;Graham;Mov Disord,2013

5. Survival and cause of death in a cohort of patients with parkinsonism: Possible clues to aetiology?;Ben-Shlomo;J Neurol Neurosurg Psychiatry,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease;Heliyon;2023-07

2. Atrial fibrillation risk on Parkinson’s disease – a systematic review and meta-analysis;Journal of Thrombosis and Thrombolysis;2023-03-25

3. Neuroimaging cerebrovascular biomarkers in Parkinson’s disease;The Neuroradiology Journal;2021-12-06

4. Cardiovascular and cerebrovascular risk markers in Parkinson’s disease: Results from a case−control study;European Journal of Neurology;2021-06-16

5. Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics;Medicinal Research Reviews;2021-06-09